| Dr Trey Dennis Durdin, MD | |
|
1904 Pine St Ste 3a, Abilene, TX 79601-2450 | |
| (325) 670-6180 | |
| (833) 437-1278 |
| Full Name | Dr Trey Dennis Durdin |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 9 Years |
| Location | 1904 Pine St Ste 3a, Abilene, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003295320 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 594025 (Texas) | Secondary |
| 208800000X | Urology | 301446-01 (New York) | Secondary |
| 208800000X | Urology | R7717 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hendrick Medical Center | Abilene, TX | Hospital |
| Haskell Memorial Hospital | Haskell, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hendrick Provider Network | 9739162181 | 231 |
News Archive
A shave biopsy is a reasonably safe and accurate method for the initial diagnosis of melanoma, according to a study published in the April issue of the Journal of the American College of Surgeons. In the past, some physicians have criticized shave biopsies for not providing accurate T (tumor) stage information, thereby complicating treatment planning.
The first ever actuarial analysis of lung cancer mortality, published today in Population Health Management Journal, provides strong evidence that earlier detection could reduce the number of late stage lung cancer deaths by over 70,000 people each year in the US.
Many scientists have noted that there is a link between inflammation or the immune response, and patient survival. One such possible relationship is the association of blood markers and the prognosis in the brain tumor called medulloblastoma.
WHITEHOUSE STATION known as MSD outside the United States and Canada, and Luminex Corporation have signed a collaboration and license agreement to develop a companion diagnostic device that will be evaluated to help screen patients for recruitment into Merck's clinical development program for MK-8931, a novel oral beta amyloid precursor protein site cleaving enzyme (BACE) inhibitor and Merck's lead investigational candidate for Alzheimer's disease (AD).
› Verified 9 days ago
| Entity Name | Muenster Hospital District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972556009 PECOS PAC ID: 6608785993 Enrollment ID: O20031106000571 |
News Archive
A shave biopsy is a reasonably safe and accurate method for the initial diagnosis of melanoma, according to a study published in the April issue of the Journal of the American College of Surgeons. In the past, some physicians have criticized shave biopsies for not providing accurate T (tumor) stage information, thereby complicating treatment planning.
The first ever actuarial analysis of lung cancer mortality, published today in Population Health Management Journal, provides strong evidence that earlier detection could reduce the number of late stage lung cancer deaths by over 70,000 people each year in the US.
Many scientists have noted that there is a link between inflammation or the immune response, and patient survival. One such possible relationship is the association of blood markers and the prognosis in the brain tumor called medulloblastoma.
WHITEHOUSE STATION known as MSD outside the United States and Canada, and Luminex Corporation have signed a collaboration and license agreement to develop a companion diagnostic device that will be evaluated to help screen patients for recruitment into Merck's clinical development program for MK-8931, a novel oral beta amyloid precursor protein site cleaving enzyme (BACE) inhibitor and Merck's lead investigational candidate for Alzheimer's disease (AD).
› Verified 9 days ago
| Entity Name | Hendrick Provider Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396961322 PECOS PAC ID: 9739162181 Enrollment ID: O20040609001047 |
News Archive
A shave biopsy is a reasonably safe and accurate method for the initial diagnosis of melanoma, according to a study published in the April issue of the Journal of the American College of Surgeons. In the past, some physicians have criticized shave biopsies for not providing accurate T (tumor) stage information, thereby complicating treatment planning.
The first ever actuarial analysis of lung cancer mortality, published today in Population Health Management Journal, provides strong evidence that earlier detection could reduce the number of late stage lung cancer deaths by over 70,000 people each year in the US.
Many scientists have noted that there is a link between inflammation or the immune response, and patient survival. One such possible relationship is the association of blood markers and the prognosis in the brain tumor called medulloblastoma.
WHITEHOUSE STATION known as MSD outside the United States and Canada, and Luminex Corporation have signed a collaboration and license agreement to develop a companion diagnostic device that will be evaluated to help screen patients for recruitment into Merck's clinical development program for MK-8931, a novel oral beta amyloid precursor protein site cleaving enzyme (BACE) inhibitor and Merck's lead investigational candidate for Alzheimer's disease (AD).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Trey Dennis Durdin, MD 1904 Pine St Ste 3a, Abilene, TX 79601-2450 Ph: (325) 670-6180 | Dr Trey Dennis Durdin, MD 1904 Pine St Ste 3a, Abilene, TX 79601-2450 Ph: (325) 670-6180 |
News Archive
A shave biopsy is a reasonably safe and accurate method for the initial diagnosis of melanoma, according to a study published in the April issue of the Journal of the American College of Surgeons. In the past, some physicians have criticized shave biopsies for not providing accurate T (tumor) stage information, thereby complicating treatment planning.
The first ever actuarial analysis of lung cancer mortality, published today in Population Health Management Journal, provides strong evidence that earlier detection could reduce the number of late stage lung cancer deaths by over 70,000 people each year in the US.
Many scientists have noted that there is a link between inflammation or the immune response, and patient survival. One such possible relationship is the association of blood markers and the prognosis in the brain tumor called medulloblastoma.
WHITEHOUSE STATION known as MSD outside the United States and Canada, and Luminex Corporation have signed a collaboration and license agreement to develop a companion diagnostic device that will be evaluated to help screen patients for recruitment into Merck's clinical development program for MK-8931, a novel oral beta amyloid precursor protein site cleaving enzyme (BACE) inhibitor and Merck's lead investigational candidate for Alzheimer's disease (AD).
› Verified 9 days ago
Mr. Terry Johnson, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 1149 Ambler Ave, Abilene, TX 79601 Phone: 325-676-7111 | |
Tina K Schuster, DO Urology Medicare: Medicare Enrolled Practice Location: 6250 Regional Plaza, Suite 1010, Abilene, TX 79606 Phone: 325-428-5500 Fax: 325-428-5519 | |
Mr. Thomas Harrop Miller Jr., MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1904 Pine St., Ste B, Abilene, TX 79601 Phone: 325-670-6580 Fax: 325-670-6586 | |
Joseph Milton Mcclintock, M.D. Urology Medicare: Medicare Enrolled Practice Location: 6250 Regional Plz, Suite 1010, Abilene, TX 79606 Phone: 325-428-5500 Fax: 325-428-5519 |